Menu
Press Releases
Axi Recognised With ‘Best Workplace 2025’ Award by Xref Engage
February 27, 2025
AXI RECOGNISED WITH ‘BEST WORKPLACE 2025’ AWARD BY XREF ENGAGE SYDNEY, Feb. 27, 2025 (GLOBE NEWSWIRE) — Leading online FX and CFD broker Axi announced that it has been recognised
Saudi Arabia’s Ministry of Energy awards prestigious feedstock allocation for joint project between Sipchem and LyondellBasell
February 27, 2025
Award marks important milestone in feasibility study of Saudi-based world-scale steam cracker and derivatives AL KHOBAR, Kingdom of Saudi Arabia and HOUSTON, Feb. 27, 2025 (GLOBE NEWSWIRE) — Sipchem and
Bitget Updates Proof of Reserves for February 2025, Reserve Ratios Increase to 186%
February 27, 2025
VICTORIA, Seychelles, Feb. 27, 2025 (GLOBE NEWSWIRE) — Bitget, the world’s leading cryptocurrency exchange and Web3 company, has released their proof-of-reserves report for February 2025. The newest snapshot shows the
Synchronoss Technologies annonce la date de la conférence téléphonique qui fera le point sur ses résultats du quatrième trimestre et son exercice 2024
February 27, 2025
BRIDGEWATER, New Jersey, 26 févr. 2025 (GLOBE NEWSWIRE) — Synchronoss Technologies, Inc. (« Synchronoss » ou la « Société ») (NASDAQ : SNCR), un innovateur et leader mondial des plateformes
Mavenir and OXIO Powering the Next Generation of MVNOs
February 26, 2025
OXIO’s Telecom-as-a-Service Platform integrates Mavenir Packet Core, IMS and Messaging solutions on Amazon Web Services for enhanced agility RICHARDSON, Texas, Feb. 26, 2025 (GLOBE NEWSWIRE) — Mavenir, the cloud-native network
Mavenir and O2 Telefónica Germany Strengthen Partnership with Multi-Year IMS Contract Extension for Cloud-Native IMS Services
February 26, 2025
New five-year contract with Mavenir powering O2 Telefónica to transition its 4G/5G voice services to latest cloud-native technology MUNICH and BONN, Germany, Feb. 26, 2025 (GLOBE NEWSWIRE) — Mavenir, the
IAVI and Biofabri/Zendal Announce First Vaccinations in the IMAGINE Clinical Trial, a Large-scale Safety and Efficacy Trial of the Tuberculosis Vaccine Candidate MTBVAC
February 26, 2025
Tuberculosis (TB) is the world’s deadliest infectious disease, killing 1.25 million people in 2023.MTBVAC is a promising vaccine candidate being evaluated in the IMAGINE trial, a large-scale safety and efficacy
Grâce à l’IA, Bitget améliore l’efficacité de son recrutement et réduit ses délais d’embauche de 38 %
February 26, 2025
VICTORIA, Seychelles, 26 févr. 2025 (GLOBE NEWSWIRE) — Bitget, la principale Bourse de cryptomonnaies et société Web3, a publié un rapport mettant en avant l’impact révolutionnaire de l’intelligence artificielle sur
Grâce à l’IA, Bitget améliore l’efficacité de son recrutement et réduit ses délais d’embauche de 38 %
February 26, 2025
VICTORIA, Seychelles, 26 févr. 2025 (GLOBE NEWSWIRE) — Bitget, la principale Bourse de cryptomonnaies et société Web3, a publié un rapport mettant en avant l’impact révolutionnaire de l’intelligence artificielle sur
Synchronoss Technologies Announces Fourth Quarter and Full Year 2024 Earnings Call Date
February 26, 2025
BRIDGEWATER, N.J., Feb. 25, 2025 (GLOBE NEWSWIRE) — Synchronoss Technologies Inc. (“Synchronoss” or the “Company”) (Nasdaq: SNCR), a global leader and innovator in Personal Cloud platforms, will hold a conference